오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 30 mg (equivalent: risedronic acid, qty 27.84 mg) - tablet, film coated - excipient ingredients: crospovidone; hypromellose; macrogol 400; hyprolose; titanium dioxide; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; macrogol 8000; lactose monohydrate - treatment of paget's disease of bone.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 5 mg (equivalent: risedronic acid, qty 4.64 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; microcrystalline cellulose; titanium dioxide; hypromellose; crospovidone; hyprolose; colloidal anhydrous silica; macrogol 8000; macrogol 400; lactose monohydrate; magnesium stearate - treatment of osteoporosis. treatment of glucocorticoid-induced osteoporosis. preservation of bone mineral density in patients on long-term corticosteroid therapy.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - estradiol hemihydrate, quantity: 1 mg; progesterone, quantity: 100 mg - capsule, soft - excipient ingredients: mono- and di- glycerides; gelatin; glycerol; purified water; lauroyl macrogolglycerides; hydrolysed gelatin; allura red ac; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400 - bijuva 1/100 is indicated for use during continuous combined hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since last menses.

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - calcium carbonate 1250 mg - eq. calcium 500 mg; cholecalciferol concentrate powder form 20 mg - eq. cholecalciferol 2000 iu - chewable tablet - calcium, combinations with vitamin d and/or other drugs

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - calcium carbonate 1250 mg - eq. calcium 500 mg; cholecalciferol concentrate powder form 20 mg - eq. cholecalciferol 2000 iu - chewable tablet - calcium, combinations with vitamin d and/or other drugs

이스라엘 - 영어 - Ministry of Health

truemed ltd. - estradiol as hemihydrate - patches - estradiol as hemihydrate 3.2 mg - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - levonorgestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet, film coated - excipient ingredients: lactose; hypromellose; microcrystalline cellulose; magnesium stearate; polysorbate 80; titanium dioxide; macrogol 400; allura red ac aluminium lake; brilliant blue fcf aluminium lake - seasonique is indicated for use as an oral contraceptive.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - oxybutynin, quantity: 36 mg - drug delivery system, transdermal - excipient ingredients: triacetin; ethyl acetate; povidone; 2-ethylhexyl acrylate; hexamethylene glycol dimethacrylate; cyclohexane; dilauroyl peroxide; isopropyl alcohol; dimeticonol; methicone; dibutyltin diacetate; heptane; toluene; aminoethylaminopropyl trimethoxysilane; polyethylene terephthalate; ethylene/vinyl acetate copolymer - oxytrol is indicated for the treatment of overactive bladder with symptoms of urinary frequency, urgency or incontinence or any combination of these symptoms.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 35 mg - tablet, enteric coated - excipient ingredients: polysorbate 80; stearic acid; purified talc; microcrystalline cellulose; triethyl citrate; iron oxide yellow; magnesium stearate; disodium edetate; methacrylic acid - ethyl acrylate copolymer (1:1); sodium starch glycollate type a; simethicone; colloidal anhydrous silica - treatment of osteoporosis. treatment of glucocorticoid-induced osteoporosis. preservation of bone mineral density in patients on long term corticosteroid therapy.